Noradrenaline
Liver Transplant; Complications
University of California, Los AngelesSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 95/ 100
Competitive context
18 Active assets in the Liver Transplant; Complications cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
TACROLIMUS The Second Hospital of Tangshan | Phase 4 | BBB |
Giapreza University of California, San Francisco | Phase 4 | BBB |
Everolimus Novartis Pharmaceuticals | Phase 3 | BB |
Equine Atg University Hospital, Toulouse | Phase 4 | BB |
Sitagliptin University Health Network, Toronto | Phase 4 | BB |
View all 35 →
Same molecule, other indications
Noradrenaline is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →